Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeted NAD+ repletion via biomimetic nanoparticle enables simultaneous management of intimal hyperplasia and accelerated re-endothelialization: A proof-of-concept study toward next-generation of endothelium-protective, anti-restenotic therapy

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.10.045Source: DataRank Database

Targeted NAD+ repletion via biomimetic nanoparticle enables simultaneous management of intimal hyperplasia and accelerated re-endothelialization: A proof-of-concept study toward next-generation of endothelium-protective, anti-restenotic therapy is a research paper published in Journal of Controlled Release (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.70)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Yao Tong ORCID,Ruosen Xie ORCID,Zhanpeng Zhang ORCID,Zain Husain Islam ORCID,Kaijie Zhang ORCID

Live enrichment

PubMed:39461367 PMC:PMC11611612 OpenAlex:https://openalex.org/W4403850106

National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Grant: R21AI165977

National Heart Lung and Blood Institute

Grant: R01HL143469

National Heart Lung and Blood Institute

Grant: R01HL129785

National Institutes of Health

FWCI

1.70

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11611612/pdf/nihms-2033382.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168365924007181?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365924007181?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11611612/

Fields of Study

Coronary Interventions and DiagnosticsPARP inhibition in cancer therapyCardiac Ischemia and ReperfusionMedicineEngineeringMaterials Science

MeSH Terms

Proof of Concept StudyAnimalsCells, CulturedEndothelium, VascularHumansHyperplasiaMaleNADRats, Sprague-DawleyTunica IntimaBiomimeticsBiomimetic MaterialsEndothelial CellsCell ProliferationRatsNanoparticles

Keywords

NAD+ kinaseRestenosisNicotinamide adenine dinucleotideIntimal hyperplasiaChemistryPharmacologyIn vivoCell biologyCancer researchMedicineBiochemistryBiologyInternal medicineEnzymeStentRe-endothelializationNanotherapyNad+ Repletion